US_FDA also amended Moderna's fact sheet

Amid flurry of inappropriate booster eligibility expansion and changes by the CDC director earlier this month and renewed vaccination calls due to VACCINE RESISTANT new OMICRON variant, it’s important to remember US_FDA also amended Moderna's fact sheet to say some data suggest "there may be an increased risk of myocarditis and pericarditis in males under 40 years of age"

The US_FDA has published a memorandum behind the decision, acknowledging data from regulators suggesting higher myocarditis and pericarditis rate from moderna_vs pfizer based on data "from Canada, France, Germany, Norway, and Japan" To adequately counsel their patients regarding risks associated with various vaccine options, vaccination providers should be informed of this suggested difference."